Efficacy of Small Bowel Preparation in Capsule Endoscopy

NCT ID: NCT01267981

Last Updated: 2024-08-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

858 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-09-30

Study Completion Date

2016-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The best preparation of small bowel is still unknown. The primary aim of this study is to evaluate the polyethylene glycol (PEG) impact of small bowel preparation for unexplained gastrointestinal bleeding exploration. Three different preparations are evaluated in this study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Now days, the endoscopic video-capsule is the more appropriate exam for unexplained gastrointestinal bleeding exploration. The responsible damage of this unexplained bleeding are frequently small vascular damages, hard to be detected in the bowel or ulcerations or tumors. The exam quality can be limited by food residues, bubbles or bile.

30% of damage are probably undetectable because of a lack of visibility. An efficient preparation will probably increased the quality of the video-capsule exploration.

The bowel exploration by endoscopy video-capsule will be realized in the usual condition. The study included 4 steps:

1. Inclusion
2. Randomization
3. Video-capsule exploration
4. Reading of the video-capsule exam by endoscopist doctors who are in blind.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastrointestinal Bleedings

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Preparation 1

Standard diet: the day before video-capsule exploration : Drink only clears liquids after the lunch, fasting from 22 hours except usual drugs with a mouthful water.

Group Type PLACEBO_COMPARATOR

Standard diet

Intervention Type DRUG

After the lunch the day before the exploration, drink only clear liquids and stop solid food.

From 10 pm, stay fasting, don't drink except the usual drugs taken with mouthful of water until the exploration by video-capsule endoscopy.

Preparation 2

Standard diet : the day before video-capsule exploration : Drink only clears liquids after the lunch, fasting from 22 hours except usual drugs with a mouthful water.

500 ml of polyethylene glycol 30 minutes after the ingestion of video-capsule endoscopy.

Group Type ACTIVE_COMPARATOR

Standard Diet + 500 ml of polyethyleneglycol

Intervention Type DRUG

Apply the standard diet and drink 500 ml of polyethylene glycol 30 minutes after the endoscopy video-capsule ingestion.

Preparation 3

Standard diet : the day before video-capsule exploration : Drink only clears liquids after the lunch, fasting from 22 hours except usual drugs with a mouthful water.

2 liters of polyethylene glycol between 7 pm and 9 pm.

500 ml of polyethylene glycol, 30 minutes after the ingestion of video-capsule endoscopy.

Group Type ACTIVE_COMPARATOR

Standard diet + 2 liters of polyethylene glycol the day before + 500ml of polyethylene glycol

Intervention Type DRUG

apply the standard diet and drink 2 liters of polyethylene glycol between 19h and 21h the day before exploration. Then drink 500 ml of polyethylene glycol 30 minutes after the endoscopy video-capsule ingestion.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard diet

After the lunch the day before the exploration, drink only clear liquids and stop solid food.

From 10 pm, stay fasting, don't drink except the usual drugs taken with mouthful of water until the exploration by video-capsule endoscopy.

Intervention Type DRUG

Standard Diet + 500 ml of polyethyleneglycol

Apply the standard diet and drink 500 ml of polyethylene glycol 30 minutes after the endoscopy video-capsule ingestion.

Intervention Type DRUG

Standard diet + 2 liters of polyethylene glycol the day before + 500ml of polyethylene glycol

apply the standard diet and drink 2 liters of polyethylene glycol between 19h and 21h the day before exploration. Then drink 500 ml of polyethylene glycol 30 minutes after the endoscopy video-capsule ingestion.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \>= 18 years old.
* Patients who have an indication for video-capsule endoscopy exploration for unexplained gastrointestinal bleeding associated with anaemia (man : haemoglobin \<13 g/dl and woman haemoglobin \<12g/dl)
* Less than one year Endoscopic assessment by colonoscopy and gastroscopy
* Not participated to an another clinic study.
* Written consent.

Exclusion Criteria

* Age\<18 years old.
* General physical health deterioration such as dehydration or cardiac insufficiency.
* Clinical or radiological suspicion of digestive stenosis.
* Oral iron taking in the 4 days before video-capsule exploration.
* Functional or organic disorders of the gulp
* Pregnant women.
* Sensibility known about the polyethylene glycol.
* No signed consent.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ministry of Health, France

OTHER_GOV

Sponsor Role collaborator

University Hospital, Brest

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Franck CHOLET, MD

Role: PRINCIPAL_INVESTIGATOR

CHRU Brest

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier d'Avignon

Avignon, , France

Site Status

Cabinet privé

Béziers, , France

Site Status

Centre Hospitalier d'Avicenne

Bobigny, , France

Site Status

CHOLET

Brest, , France

Site Status

CHRU de Lille

Lille, , France

Site Status

Saint Philibert Hospital

Lomme, , France

Site Status

CH Bretagne Sud

Lorient, , France

Site Status

Edouard Herriot Hospital

Lyon, , France

Site Status

Hôpital de La Conception

Marseille, , France

Site Status

Hôpital de la Timone

Marseille, , France

Site Status

Centre Hospitalier Universitaire de Nice

Nice, , France

Site Status

Hôpital Cochin

Paris, , France

Site Status

Höpital Européen Geores Pompidou

Paris, , France

Site Status

CH de Cornouaille Quimper

Quimper, , France

Site Status

Centre Hospitalier de Saint Brieuc

Saint-Brieuc, , France

Site Status

Hôpital Privé de L'Est Lyonnais

Saint-Priest, , France

Site Status

CH Bretagne Atlantique

Vannes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Rahmi G, Cholet F, Gaudric M, Filippi J, Duburque C, Bramli S, Quentin V, Alavi Z, Nowak E, Saurin JC, Cellier C, Queneherve L; PREPINTEST working group. Effect of Different Modalities of Purgative Preparation on the Diagnostic Yield of Small Bowel Capsule for the Exploration of Suspected Small Bowel Bleeding: A Multicenter Randomized Controlled Trial. Am J Gastroenterol. 2022 Feb 1;117(2):327-335. doi: 10.14309/ajg.0000000000001597.

Reference Type DERIVED
PMID: 35041627 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RB 09.091

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.